UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

2018-12-13

Document Type

Blog Post

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Insurance | Pharmacoeconomics and Pharmaceutical Economics

Abstract

The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for incentives to lower drug list prices, including removing rebates. Our clinical consultant Stephanie Tran continues our pharmacy blog series with an assessment of this potential change & its impacts.

Keywords

rebates, drug prices, Department of Health and Human Services, Food and Drug Administration, price increases, generic competition

Rights and Permissions

© 2018 University of Massachusetts Medical School

Journal/Book/Conference Title

Commonwealth Medicine Blog

Comments

Blog post to Commonwealth Medicine's website - view blog post online

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.